Skip to main content
OpenTrials
Completed

NCT Number: NCT05060874

Gripwise® Versus JAMAR®

It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement.

Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones.

This cross-sectional study will include 348 patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age-Related Sarcopenia

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Caen University Hospital

Caen, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • men and women aged 65 or over
  • affiliated to a health insurance
  • Francophone.

Exclusion criteria

  • - refusal to participate
  • unable to communicate
  • unable to use both hands (dominant and non-dominant)

Treatment and study plan

Primary outcomes

  1. Comparison between Jamar® and Gripwise® values for grip strength measurement

    Time frame: day1

    Intra-class correlation between the best values obtained with each device

Secondary outcomes

  1. comparison according to the patient's position

    Time frame: day1

    correlations of dynamometer measurements between patients assessed in the sitting or lying position

  2. number of attempt to reach the maximum value

    Time frame: day1

    Comparison of the three measurements obtained for each patient with each device

  3. factors influencing detected weakness

    Time frame: day1

    significant difference in the rate of women detected as weak with a handgrip <16kg and men <27kg, between the different reasons for hospitalisation, the number of days of hospitalisation, and between the different chronic cancerous and non-cancerous pathologies (Updated Charlson Comorbidity Index), the age groups 65-79 years and ≥80 years

  4. satisfaction using the devices

    Time frame: day1

    rate of patients finding one of both device easier to use

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Official study title

Comparison of Gripstrength Assessment Between the Gripwise® and JAMAR® Dynamometers in Elderly Inpatients

Acronym: HANDGAGES

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Sep 29, 2021
Registry last updated
Nov 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.